Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease

Completed · Phase 4

Conditions studied: Graves Disease, Hyperthyroidism

In brief

The purpose of this study is to determine whether a brief course of SSKI (saturated solution of potassium iodide) administered preoperatively provides any benefit in the surgical management of patients undergoing thyroidectomy as definitive management of their Graves Disease.

Key facts

Study ID

NCT00946296

Run by

University of Massachusetts, Worcester

People needed

36

Starts

2005-04-01

Expected to finish

2013-04-01

Last updated by the study team

2015-12-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients with a clinical diagnosis of Graves Disease
• Patients who have selected surgical resection as treatment of their Graves Disease
• Prior use of anti thyroid medication so that patient is clinically and biochemically euthyroid

You may not qualify if…

• Patients deemed unfit for surgery by operating surgeon or anesthesist
• Patients who are clinically hyperthyroid or have T3 or T4 levels 2X the upper limit of normal

Where it is running

• UMASS Memorial Health Care — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.